Solesence, Inc. (SLSN)
NASDAQ: SLSN · Real-Time Price · USD
3.830
+0.200 (5.51%)
At close: Aug 15, 2025, 4:00 PM
3.900
+0.070 (1.83%)
After-hours: Aug 15, 2025, 4:04 PM EDT

Company Description

Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States.

The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin health products, such as sunscreens and daily care products; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, and medical diagnostics applications.

The company was formerly known as Nanophase Technologies Corporation and changed its name to Solesence, Inc. in March 2025.

Solesence, Inc. was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Solesence, Inc.
Solesence logo
CountryUnited States
Founded1989
IndustryHousehold & Personal Products
SectorConsumer Staples
Employees98
CEOJess Jankowski

Contact Details

Address:
1319 Marquette Drive
Romeoville, Illinois 60446
United States
Phone630 771 6708
Websitesolesence.com

Stock Details

Ticker SymbolSLSN
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000883107
ISIN NumberUS6300791018
Employer ID36-3687863
SIC Code2844

Key Executives

NamePosition
Jess A. JankowskiPresident, Chief Executive Officer, Chief Financial Officer, Secretary and Director
Kevin CuretonChief Operating Officer

Latest SEC Filings

DateTypeTitle
Aug 14, 202510-QQuarterly Report
Jul 31, 20258-KCurrent Report
Jul 30, 2025DEF 14AOther definitive proxy statements
Jun 9, 20258-KCurrent Report
Jun 2, 2025SCHEDULE 13D/AFiling
Jun 2, 20258-KCurrent Report
May 13, 202510-QQuarterly Report
May 7, 20258-KCurrent Report
Apr 7, 20258-KCurrent Report
Apr 7, 2025CERTCertification by an exchange approving securities for listing